The combination of daclatasvir, a hepatitis C virus (HCV) NS5A inhibitor, and the NS5B inhibitor sofosbuvir has shown efficacy in patients with HCV monoinfection. Data are lacking on the efficacy and ...

Greg Dore receives funding from Gilead, Abbvie, Merck, and Bristol-Myers Squibb. Marianne Martinello does not work for, consult, own shares in or receive funding from any company or organization that ...

Up-to-date prescription details regarding Ledipasvir and Sofosbuvir are provided here. Understand it's uses, recommended dosages, its indications, how to take, when to take, when not to take, side ...

Please provide your email address to receive an email when new articles are posted on . Sofosbuvir, mirabegron and nintedanib — all approved within the past 9 years — are among the drugs associated ...

Please provide your email address to receive an email when new articles are posted on . High rates of sustained virologic response were achieved after 12 weeks of sofosbuvir/velpatasvir plus tenofovir ...

The appraisal committee (section 5) considered evidence submitted by Gilead Sciences and a review of this submission by the evidence review group (ERG). See the committee papers for full details of ...

With Gift Aid, your generous donation of £10 would be worth £12.50 at no extra cost to you. Yes, I want to Gift Aid any donations made to NAM now, in the future and in the past four years I am a UK ...

Discover comprehensive details about Sofosbuvir, including its pronunciation, uses, dosage instructions, indications, and guidelines on how and when to take it or avoid it. The updated prescription ...

The Appraisal Committee considered evidence submitted by Gilead Sciences and a review of the submissions by the Evidence Review Group (ERG). The company provided clinical‑effectiveness evidence, ...